Desktop Scanners

PRODUCTS

  • QPA1314 is a high-power GaN MMIC amplifier for Satcom applications. The amplifier is packaged for easy integration and is ideal for both commercial and military markets.

  • The Future of Precision Medicine: Radiopharmaceutical Preparation for Targeted Diagnostics and Treatment

    Safer and More Effective Radiopharmaceutical Production With Germfree's Advanced Cleanrooms and Equipment Solutions

    Radiopharmaceuticals are drugs that contain radioactive isotopes and are used as diagnostic and therapeutic agents. Due to the hazardous nature of radioisotopes, lead shielded aseptic processing equipment is required for their production and handling. These cleanrooms have specific requirements such as HEPA exhaust and biosecurity features to prevent contamination and protect workers.

    Germfree’s expertise in designing facilities and equipment for complex critical environments ensures compliant radiopharmaceutical preparation and production at varying scales. Radiopharmaceuticals play a crucial role in advanced therapies, including nuclear medicine and cancer treatment, and are a rapidly growing sector of the biopharmaceutical industry.

  • We work as a single provider to empower patient and site participation in clinical trials. Our Integrated Trial Services team is dedicated to creating partnerships with our Sponsor and CRO clients, building strategic and unique combinations of solutions to accelerate trial timelines.

  • Designed for versatility throughout the bioproduction workflow with patented performance of Metenova® Zero Gravity mixing technology, now optimized for single-use applications. This cutting edge system offers unmatched performance, ease of use, and scalability for both Upstream and Downstream bioprocessing professionals seeking cost-effective, efficent, and easy-to-deploy solutions.

  • Physiologix human growth factor concentrate is a cGMP, xeno-free media supplement for stem cells and T cells that replaces FBS or human serum in media formulations.

WHITE PAPERS AND CASE STUDIES

NEWS